Abstract
Most angiotensin II antagonists in the literature contain the biphenyltetrazole moiety. We now wish to report a new, more rigidized biphenyl replacement, namely the dibenzobicyclo[2.2.2.]octane scaffold. It was designed on the basis of the three-dimensional conformation of the biphenyltetrazole moiety of losartan, the prototypic angiotensin II antagonist. This biphenyltetrazole replacement fixes both the imidazole and the negatively charged (at physiological pH) tetrazole in the same areas of space where they are located in losartan. Other scaffolds such as a fluorene and Rebek's Cleft are also discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.